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Abstract RNA editing is a post-transcriptional pro-
cess, which results in base substitution modifications
to RNA. It is an important process in generating
protein diversity through amino acid substitution and
the modulation of splicing events. Previous studies
have suggested a link between gene-specific reduc-
tions in adenosine to inosine RNA editing and aging in
the human brain. Here we demonstrate that changes in
RNA editing observed in humans with age are not
observed during aging in healthy rats. Furthermore, we
identify a conserved editing site in rats, in Cog3. We
propose that either age-related changes in RNA
editing are specific to primates or humans, or that
they are the manifestation of disease pathology. Since
rodents are often used as model organisms for
studying aging, these findings demonstrate the impor-
tance of understanding species-specific differences in
RNA biology during aging.
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Introduction
Adenosine to inosine (A-to-I) RNA editing is a post-
transcriptional process that alters the sequences of
RNA molecules. The adenosine deaminases ADAR
and ADARB1 convert specific adenosine residues on
RNA to inosine bases. During translation, sequencing,
and splicing, inosine is recognized as guanosine.
Therefore, A-to-I RNA editing has important impli-
cations in altering specific amino acids, miRNA
targeting, and in the modulation of alternative splicing
(Nishikura 2010).
Targets of A-to-I RNA editing are often genes
involved in neurotransmission in the central nervous
system (CNS), although editing is known to occur in
other tissues. Changes in A-to-I RNA editing have been
implicated in the development of cancer inside and
outside the CNS (Cenci et al. 2008; Galeano et al. 2010;
Paz et al. 2007; Shah et al. 2009), and in various
neurodegenerative diseases, such as dyschromatosis
symmetrica hereditaria (DSH), amyotrophic lateral
sclerosis (ALS), Alzheimer’s disease, and Huntington’s
disease. In addition, the process has implications in
epilepsy, depression, schizophrenia and is associated
with a greater risk of suicide (Akbarian et al. 1995;
Farajollahi and Maas 2010; Maas et al. 2006). More
recently it was identified that single nucleotide poly-
morphisms in ADARB1 and ADARB2 are associated
with extreme longevity in humans (Sebastiani et al.
2009). Furthermore, it was recently observed that editing
of the p53-inducible Cyfip2 (Cytoplasmic FMR1
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interacting protein 2) significantly declines with age in
human cerebral cortex. However, editing of Gabra3
(Gamma-aminobutyric acid A receptor subunit alpha 3)
was found not to decline with age in humans. This
suggests that RNA editing efficiency may be linked to
aging in a gene-specific manner (Nicholas et al. 2010).
Humans are known to have far more targets of A-to-
I RNA editing than rodents, due to the spread of Alu
repeats during human evolution (Neeman et al. 2006).
However, there are several known targets of A-to-I
RNA editing that are conserved from rodents to
humans (Levanon et al. 2005). The brown rat, Rattus
norvegicus, is a well-established model species for
studying aging and has been used in neurological
research for many years. The brown rat is held as a
model for mammalian behavioral and neurodegener-
ative studies (Jacob 1999; Wood et al. 2013). Com-
parative approaches are essential to fully understand
aging; hence it is crucial to establish differences
between humans and rodents to assess their impor-
tance to inform about human aging. Functional
alterations, through RNA editing or other means,
may also contribute to species differences in aging.
Since studies linking RNA editing to aging have only
been reported in humans, this study aimed to inves-
tigate whether the effect of age on RNA editing
efficacy is conserved in the brown rat.
Methods
Rat tissues used in this study were supplied from a
previous experiment (Merry et al. 2008). All animal
husbandry procedures undertaken in this study were
carried out in accordance with the provisions of the
United Kingdom Animals (Scientific Procedures) Act
1986. Male BN rats (SubstrainBN/SsNOlaHSD) were
obtained from Harlan UK at 21–28 days of age and
maintained under barrier conditions on a 12 h light:
12 h dark cycle (08:00–20:00). The health status of the
rats was monitored at regular intervals through the
screening of sentinel animals. All rats were fed
ad libitum and sacrificed at 6, 12, and 28 months of
age. None of the animals exhibited any signs of
pathology when sacrificed. Each age group had six
rats, from which brain samples were taken, flash
frozen, and stored at -80 C.
RNA was extracted from cerebral cortex of rats
using the RNeasy lipid tissue kit (Qiagen). The quality
of the extracted RNA was assessed using the Agilent
2100 Bioanalyzer; all RNA integrity numbers (RINs)
were above 8.0, indicating that the RNA had minimal
degradation. For RNA extraction from brain tissue,
RIN [ 8 represents a high quality threshold (Bett-
scheider et al. 2011). The samples were pooled in pairs
(leaving 3 samples per age group). Ribosomal RNA
was removed from the pooled samples using the
Eukaryote Ribominus Kit (Invitrogen) and confirmed
with the Agilent 2100 Bioanalyzer.
RNA-seq data was generated by SOLiD sequenc-
ing (Applied Biosystems) from these samples in a
previous study (Wood et al. 2013). The RNA-seq
results from the SOLiD system were output as color
space FASTA and quality files. These were con-
verted into FASTQ format using a Python script from
Galaxy (http://main.g2.bx.psu.edu/). The FASTQ
files were mapped to the Ensembl release 65 rat
reference genome (RGSC 3.4 assembly, May 2010
gene build) using Bowtie (Langmead et al. 2009) and
settings appropriate to SOLiD data. For each sample,
*33.6 million reads were generated (range,
29.5–39.8 million reads). On average 16.7 million
reads per sample were mapped to the reference
genome (range, 13.8–21.4 million reads, *50 % of
reads generated were mapped). All data have been
submitted to GEO under the accession GSE34272
(Wood et al. 2013). A mismatch analysis was per-
formed on the aligned reads using Bambino in order
to generate candidate editing sites (Edmonson et al.
2011). These candidates were selected using custom
Python scripts for A-G mismatches within exons in
genes on the positive strand, and T-C mismatches on
the negative strand. Results were narrowed by
selecting for non-synonymous mismatches and for
those with a high number of read counts. Selected
candidate targets were reverse transcribed using
M-MLV reverse transcriptase (Invitrogen) and
amplified by PCR using rTaq (TaKaRa). Editing
levels were then analyzed by Sanger sequencing
using the 3730 DNA Analyzer (Applied Biosystems)
and quantifications were calculated by peak height
analysis (Eggington et al. 2011).
Results
Cerebral cortex from 6, 12, and 28 month old rats were
studied by RNA-seq to identify transcriptomic
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differences that occur during aging (Wood et al. 2013).
These data were used to identify mismatches between
the sequenced reads and the genome. Using Bambino
(Edmonson et al. 2011), we identified candidate A-to-I
RNA editing sites in the brown rat and used Sanger
sequencing to validate these from RNA extracted from
the cerebral cortex of the same rats. This analysis led
to the identification of a new editing site in rats in the
conserved oligomeric Golgi complex subunit 3 (Cog3)
at position Chr15:61477456 (rn5 rat genome build).
This modification results in a codon change from AUU
to IUU, and an amino acid change from isoleucine to
valine. Editing of this site has previously been
reported in humans (Shah et al. 2009), and more
recently in mice (Danecek et al. 2012), demonstrating
conservation of the editing site between humans and
rodents.
Using Sanger sequencing, editing levels of known
conserved targets of A-to-I RNA editing were ana-
lyzed from the cerebral cortex of rats used in the RNA-
seq: Gabra3, Cyfip2, Kcna1, Flna, and Blcap (which
has three editing sites, known as Y/C, Q/R, and K/R),
and the newly identified site in Cog3, using primers
given in Table 1. The RNA editing enzymes, ADAR
and ADARB1, have different specificities for base
sequence and structure of their target sites (Riedmann
et al. 2008). Therefore, different targets of RNA
editing may be edited by both enzymes, or
preferentially by just one. These differences have
previously been hypothesized as a possible cause of
the gene-specific RNA editing changes observed
during aging in humans (Nicholas et al. 2010). The
RNA editing sites studied here are targeted to different
degrees by ADAR and ADARB1. For example, while
Cyfip2 and Flna are targeted primarily by ADARB1
(Riedmann et al. 2008), Gabra3 is targeted by both
ADARs (Ohlson et al. 2007), and Blcap is targeted
mostly by ADAR (Riedmann et al. 2008). Therefore, it
should be possible to identify whether any protein-
specific age-related changes in RNA editing occur in
the RNA editing targets that were studied.
The mean lifespan of the rat strain used for this
study was 28.06 ± 0.72 months (n = 102), deter-
mined from a previous study (Merry et al. 2008).
Therefore the ages of the rats used in this study, aged 6,
12, and 28 months represent 21.4, 42.7, and 99.8 % of
the mean lifespan, respectively. We compared the
editing levels of six human cerebral cortex samples
from 76 to 80 year old individuals (mean 77.7 years)
from a previous study (Nicholas et al. 2010) to the
levels of editing present in 28 month old rats. The
76–80 year old human samples analyzed represented
99.5 % of the mean human lifespan, assuming a
human life expectancy of 78.0 years (United States
Census Bureau 2012). These samples were compared
based on their similar sample size, ages, and percent-
age of mean lifespan. RNA editing levels of Gabra3
remain similar in 28-month-old rats (93.2 % ± 1.5)
and 76–80 year old humans (91.5 % ± 2.9). Editing
levels of Cyfip2 also remain high in 28-month-old rats
(88.0 % ± 1.3). However, editing of Cyfip2 declines
to 70.9 % ± 5.7 in 76–80 year old humans. Thus,
age-matched 28-month-old rats maintain high levels
of Cyfip2 editing, compared to 76–80 year old
humans.
Although we observe differences in RNA editing
between humans and rats, we do not identify signif-
icant changes in RNA editing levels of Gabra3,
Cyfip2, Kcna1, Flna, Blcap or Cog3 with age in rats by
one-way ANOVA (Fig. 1; Table S1) or collectively by
two-way ANOVA, F(2,128) = 0.430, p = 0.652.
Importantly, no change was identified for Cyfip2
(r2 = 0.021), in contrast to humans (Nicholas et al.
2010). Therefore, RNA editing of these targets in the
brown rat is maintained throughout the average adult
lifespan.
Table 1 Oligonucleotide sequences used for PCR amplifica-
tion and sequencing of the RNA editing targets, Gabra3, Cy-
fip2, Kcna1, Flna, Cog3, and Blcap
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Discussion
We report a new editing site in the brown rat in Cog3
which causes an amino acid change from isoleucine to
valine. This site has recently been identified in humans
and mice, demonstrating its evolutionary conservation
(Danecek et al. 2012; Shah et al. 2009). Cog3 is part of
a protein complex in the Golgi apparatus that localises
to the membrane, and is required for correct protein
glycosylation (Shestakova et al. 2006). It has not yet
been identified whether editing of Cog3 can modulate
its functionality, although its conservation between
rodents and humans implies that it could have a
functional role.
Conserved targets of RNA editing were studied in
the brown rat, in order to investigate whether an age-
related decline of RNA editing is conserved from
humans through to the brown rat. Editing levels of
Gabra3, Cyfip2, Kcna1, Flna, Blcap, and Cog3 were
analyzed in 6-, 12-, and 28-month-old rats. We
demonstrate that there are no significant differences
in editing levels between RNA editing targets at any
age in rat cerebral cortex. Unlike in elderly humans
(Nicholas et al. 2010), 28-month-old rats show no
deterioration of RNA editing in the targets tested in
this study. Thus, within the average lifespan of the rat,
we see no evidence for changes in RNA editing with
age. We cannot, however, rule out the possibility that
RNA editing levels may decrease in rats after the age
of 28 months. In this study, only male rats were
analyzed, so sex specific effects cannot be ruled out.
However, no differences in RNA editing have been
reported to date between sexes (Zhu et al. 2012), and
no differences in gender were observed during aging
in humans (Nicholas et al. 2010).
At younger ages, humans and rats appear to show
no differences in RNA editing of Cyfip2 and Gabra3.
In elderly humans it was identified that editing of
Cyfip2 was reduced showing a significant decline with
age (Nicholas et al. 2010). In contrast, we identify that
editing levels of Cyfip2 are maintained in the rat across
the mean lifespan, from 6- to 28-months of age. This
suggests that the gene-specific link between RNA
editing of Cyfip2 and aging is not conserved between
humans and rats. Due to the increased lifespan within

















Fig. 1 RNA editing percentages of the conserved target sites
within Gabra3, Cyfip2, Kcna1, Flna, Cog3, and the Y/C, Q/R,
and K/R sites of Blcap, were quantified from cerebral cortex of
rats aged 6, 12, and 28 months. Quantification was determined
by Sanger sequencing and peak height analysis. Error bars
represent one standard deviation from the mean
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to be highly prevalent in the primate lineage (Eisen-
berg et al. 2005), our hypothesis is that this gene-
specific link to aging may be confined to primates.
Alternatively, the decrease in RNA editing in
Cyfip2 found in humans could be due to disease
pathology. Many human patients used in the previous
study died from heart failure (Nicholas et al. 2010). In
contrast, all the rats used in our study were sacrificed
when healthy. Although there has been no report of an
association between changes in RNA editing and heart
failure, it remains a possibility that this could have
affected RNA editing, whether directly or indirectly.
Rodent models are frequently used in biogeronto-
logical studies, and although many aspects of aging
are shared between rodents and humans, there are
many important differences in their physiology,
susceptibility to diseases, and their population demo-
graphics (Demetrius 2005). Furthermore, it has
recently been shown that gene expression changes in
response to inflammation are considerably different
between mice and humans (Seok et al. 2013). This
demonstrates that not only at the physiological level,
but also at the underlying genetic level, the responses
of rodent models to biological processes can be very
different to those in humans. Since rodents are often
used as model organisms for studying aging, it is vital
to understand how biological processes, such as RNA
editing, are differentially affected during aging,
depending on the species.
This study demonstrates that the differences in
RNA editing between rodents and humans are an
important consideration when using rodent models to
study aging. In contrary to previous findings in
humans, we report that A-to-I RNA editing of
evolutionarily conserved targets does not decline with
age in rats. Furthermore, we identify that the gene-
specific link of RNA editing to aging, which was
identified in humans, is not conserved through to the
brown rat. We interpret that age-related changes
observed in RNA editing could be specific to primates
or humans, or that they may be a result of pathology, as
opposed to aging per se.
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